Literature DB >> 17132884

The prevalence of hypokalemia in hospitalized patients with infectious diseases problem at Cipto Mangunkusumo Hospital, Jakarta.

Djoko Widodo1, Budi Setiawan, Khie Chen, Leonard Nainggolan, Widayat Djoko Santoso.   

Abstract

AIM: to know the prevalence of hypokalemia that occurs in hospitalized patients with infectious diseases.
METHODS: a cross sectional study was carried out in the internal ward Cipto Mangunkusumo General Hospital in Jakarta from December 2005 until June 2006. All hospitalized patients with infectious diseases receiving "replacement solution" were included in this study. We collected the blood sample to perform the serum potassium level at the time of admission and discharge.
RESULTS: one hundred and five patients were enrolled in this study; consisting of 44 males and 61 females. The age ranged from 14 to 70 years old. The most common infectious diseases were dengue fever, while the underlying diseases were hepatobiliary disorders. "Replacement solutions" which were given, were ringer's lactate 91%, normal saline 8%, and ringer's acetate 1%. Prevalence of hypokalemia among the hospitalized patients, on admission was 24 patients (23%) and during hospitalization was 39 patients (37%). The mean level of hypokalemia on admission was 3.11 + SD 0.37 mEq/L (range from 1.7 to 3.4 mEq/L) and during hospitalization was 3.13 + SD 0.25 mEq/L (range from 2.5 to 3.4 mEq/L). On admission, the ratio of mild : moderate : severe hypokalemia is 22 : 2 : 1. And at discharge the ratio of mild to moderate hypokalemia becomes 19 : 6.
CONCLUSION: the prevalence of hypokalemia in hospitalized patients with infectious disease in Cipto Mangkunkusumo's Hospital, Jakarta is 23%. Further studies are needed to know the contributing factors including the usage of 'intravenous fluid' in relations to hypokalemic state during hospitalization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132884

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  12 in total

1.  Acute hypokalaemic quadriparesis in dengue fever.

Authors:  Amitava Roy; Anil Kumar Tripathi; Shailendra Prasad Verma; Himanshu Reddy; Nirdesh Jain
Journal:  BMJ Case Rep       Date:  2011-07-27

Review 2.  Pathophysiology and management of hypokalemia: a clinical perspective.

Authors:  Robert J Unwin; Friedrich C Luft; David G Shirley
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

3.  Hypokalaemic quadriparesis: an unusual manifestation of dengue fever.

Authors:  Durgesh Kumar Gupta; A K Vaish; Rajesh Kumar Arya; Shyam Chand Chaudhary
Journal:  BMJ Case Rep       Date:  2011-06-17

4.  Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling study.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-15       Impact factor: 2.745

5.  Acute neuromuscular weakness associated with dengue infection.

Authors:  Harmanjit Singh Hira; Amandeep Kaur; Anuj Shukla
Journal:  J Neurosci Rural Pract       Date:  2012-01

6.  Hypokalemic quadriparesis: An unusual manifestation of dengue fever.

Authors:  Manish Gutch; Avinash Agarwal; Amrendra Amar
Journal:  J Nat Sci Biol Med       Date:  2012-01

7.  Hypokalemic quadriparesis in dengue.

Authors:  Vikas Mishra; Rishit Harbada; Akhilesh Sharma; Meenakshi Mishra
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

8.  Influence of herbal complexes containing licorice on potassium levels: a retrospective study.

Authors:  WooSang Jung; SeungWon Kwon; JinWook Im; SeongUk Park; SangKwan Moon; JungMi Park; ChangNam Ko; KiHo Cho
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-19       Impact factor: 2.629

9.  The Tolerability and Efficacy of Oral Isotonic Solution versus Plain Water in Dengue Patients: A Randomized Clinical Trial.

Authors:  Leonard Nainggolan; Saptawati Bardosono; Ermita I Ibrahim Ilyas
Journal:  Indian J Community Med       Date:  2018 Jan-Mar

Review 10.  Epidemiology, prognosis and management of potassium disorders in Covid-19.

Authors:  Maryam Noori; Seyed A Nejadghaderi; Mark J M Sullman; Kristin Carson-Chahhoud; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-06-02       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.